LGBTQ+ Inclusive Policies Boost Mpox Vaccination Rates Across U.S. States

A study reveals that states with stronger LGBTQ+ protections in the US saw significantly higher mpox vaccination rates during the 2022–2023 outbreak, highlighting the importance of inclusive policies in public health.
A recent study highlights a significant link between LGBTQ+ equality laws and mpox vaccination rates in the United States during the 2022–2023 outbreak. Researchers from CUNY School of Public Health found that states with stronger legal protections for LGBTQ+ communities experienced notably higher vaccination uptake compared to those with fewer protections. Specifically, states with high LGBTQ+ equality had around four times the vaccination rates of states with less inclusive policies. This disparity persisted throughout different phases of the outbreak, indicating the integral role of social and policy environments in public health efforts.
The study analyzed over 1.2 million administered mpox vaccine doses across all 50 states and Washington, D.C. Interestingly, financial barriers were not a major obstacle since the vaccine was provided free nationwide. Instead, factors like societal stigma and mistrust in healthcare systems in less inclusive states likely contributed to lower vaccination levels.
Lead researcher Claudia Jimenez Castro emphasized that promoting health equity through supportive policies could enhance vaccine acceptance during health crises. Associate Professor Elizabeth Kelvin pointed out that improving legal protections for LGBTQ+ populations might be crucial in effective epidemic response strategies in the future.
This research underscores the importance of inclusive policies and environments that foster trust and participation in public health measures, especially among vulnerable communities. Strengthening such protections could lead to better health outcomes and more resilient responses to future outbreaks.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Biomarkers Offer Promising Insights for Treating Aggressive Prostate Cancer
A clinical trial at UC Davis highlights the potential of genetic testing and biomarkers, such as circulating tumor DNA, to improve treatment strategies for aggressive prostate cancer, offering hope for better personalized therapies.
Study Shows Wearable Devices Vary in Accuracy for Fitness Metrics
A recent study examines the accuracy of wearable fitness devices like Apple Watch, highlighting their strengths in tracking heart rate and steps but cautioning about energy expenditure errors. Learn how these devices can support your health journey while recognizing their limitations.
Breakthrough in Kidney Regenerative Medicine: Human Kidney Organoids Grown from Stem Cells Mirroring Fetal Development
Researchers have developed human kidney organoids from tissue stem cells that mirror fetal kidney development, offering new avenues for studying kidney diseases and regenerative therapies.
Lab-Grown 'Tiny Hearts' Offer New Hope for Heart Disease Patients
Innovative lab-grown heart tissues, or cardiac organoids, mimic adult human heart muscle and hold promise for advancing drug testing and treatment for genetic and acquired heart conditions in both children and adults.



